Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.
about
Oxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and TherapiesPharmacology and Clinical Drug Candidates in Redox MedicineMelanocytes from Patients Affected by Ullrich Congenital Muscular Dystrophy and Bethlem Myopathy have Dysfunctional Mitochondria That Can be Rescued with Cyclophilin Inhibitors.Novel pathogenic variants and genes for myopathies identified by whole exome sequencingThe Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.Denervated muscle fibers induce mitochondrial peroxide generation in neighboring innervated fibers: Role in muscle aging.Melatonin prevents mitochondrial dysfunctions and death in differentiated skeletal muscle cells.Contribution of monoamine oxidases to vascular oxidative stress in patients with end-stage renal disease requiring hemodialysis.Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in Mice and in Myogenic Cultures From DMD Patients
P2860
Q26769962-2203593A-4E59-4331-82B7-C8F506A08C99Q26785525-C889DDAF-7DA9-4858-893B-7A8D3447F7A3Q34547398-9CA4ADE1-D8FD-48B0-A35A-811F4F07BFFEQ35907744-217D95AD-5FE5-4E45-BCC9-F91752A3A864Q36146320-1C3738A2-40DB-46A1-A3C6-511234712FA9Q38888524-2E6E91EB-01DA-4DA0-9857-00F9DD2733EFQ42704750-AE3FAEAF-4DF6-481B-B3CA-471B517789E9Q48350062-FC61A6B4-1359-4F12-A06E-DCE1A180E9C6Q53137131-4BBD6A8E-0A1F-470E-A41D-1A5B494837C4Q58781307-E2303B28-485C-48B3-980B-0E5941FBA0D8
P2860
Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@ast
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@en
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@nl
type
label
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@ast
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@en
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@nl
prefLabel
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@ast
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@en
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@nl
P2093
P2860
P50
P1476
Monoamine oxidase inhibition p ...... s with collagen VI myopathies.
@en
P2093
P2860
P356
10.1016/J.FREERADBIOMED.2014.07.006
P577
2014-07-10T00:00:00Z